Literature DB >> 22187448

Clinical considerations of heritable factors in common heart failure.

Thomas P Cappola1, Gerald W Dorn.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22187448      PMCID： PMC3244682          DOI： 10.1161/CIRCGENETICS.110.959379

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN： 1942-3268


× No keyword cloud information.
  74 in total

1.  The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity.

Authors:  Heike Bruck; Kirsten Leineweber; Thomas Temme; Melanie Weber; Gerd Heusch; Thomas Philipp; Otto-Erich Brodde
Journal:  J Am Coll Cardiol       Date:  2005-11-04       Impact factor: 24.094

2.  2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.

Authors:  Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2009-03-26       Impact factor: 29.690

3.  Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction.

Authors:  Barry R Palmer; Anna P Pilbrow; Tim G Yandle; Chris M Frampton; A Mark Richards; M Gary Nicholls; Vicky A Cameron
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

4.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

5.  beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.

Authors:  Steven G Terra; Daniel F Pauly; Craig R Lee; J Herbert Patterson; Kirkwood F Adams; Richard S Schofield; Bernadette S Belgado; Karen K Hamilton; Juan M Aranda; James A Hill; Hossein N Yarandi; Joseph R Walker; Michael S Phillips; Craig A Gelfand; Julie A Johnson
Journal:  Clin Pharmacol Ther       Date:  2005-03       Impact factor: 6.875

6.  Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure.

Authors:  Lynne E Wagoner; Laura L Craft; Paul Zengel; Nancy McGuire; Deborah A Rathz; Gerald W Dorn; Stephen B Liggett
Journal:  Am Heart J       Date:  2002-11       Impact factor: 4.749

7.  Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study.

Authors:  F Cambien; F Alhenc-Gelas; B Herbeth; J L Andre; R Rakotovao; M F Gonzales; J Allegrini; C Bloch
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

8.  Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death.

Authors:  A J Marian; Q T Yu; R Workman; G Greve; R Roberts
Journal:  Lancet       Date:  1993-10-30       Impact factor: 79.321

9.  Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension.

Authors:  X Jeunemaitre; R P Lifton; S C Hunt; R R Williams; J M Lalouel
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

10.  Cardiac signaling genes exhibit unexpected sequence diversity in sporadic cardiomyopathy, revealing HSPB7 polymorphisms associated with disease.

Authors:  Scot J Matkovich; Derek J Van Booven; Anna Hindes; Min Young Kang; Todd E Druley; Francesco L M Vallania; Robi D Mitra; Muredach P Reilly; Thomas P Cappola; Gerald W Dorn
Journal:  J Clin Invest       Date:  2009-12-14       Impact factor: 14.808
View more
  5 in total

Review 1.  Operationalizing Precision Cardiovascular Medicine: Three Innovations.

Authors:  Jessica J Wang; Jamil A Aboulhosn; Ira S Hofer; Aman Mahajan; Yibin Wang; Thomas M Vondriska
Journal:  Circ Res       Date:  2016-10-14       Impact factor: 17.367

Review 2.  Transcriptomic biomarkers of cardiovascular disease.

Authors:  Dawn M Pedrotty; Michael P Morley; Thomas P Cappola
Journal:  Prog Cardiovasc Dis       Date:  2012 Jul-Aug       Impact factor: 8.194

Review 3.  Genetics and heart failure: a concise guide for the clinician.

Authors:  Cecile Skrzynia; Jonathan S Berg; Monte S Willis; Brian C Jensen
Journal:  Curr Cardiol Rev       Date:  2015

4.  Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study.

Authors:  Hae-Young Lee; Wook-Jin Chung; Hui-Kyung Jeon; Hong-Seog Seo; Dong-Ju Choi; Eun-Seok Jeon; Jae-Joong Kim; Joon Han Shin; Seok-Min Kang; Sung Cil Lim; Sang-Hong Baek
Journal:  Korean J Intern Med       Date:  2016-02-16       Impact factor: 2.884

Review 5.  Contextualizing Genetics for Regional Heart Failure Care.

Authors:  Pupalan Iyngkaran; Merlin C Thomas; Renee Johnson; John French; Marcus Ilton; Peter McDonald; David L Hare; Diane Fatkin
Journal:  Curr Cardiol Rev       Date:  2016
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.